Home > Insider Trading > Filing (0001209191-16-156999)

Filing Details

Accession Number:: 0001209191-16-156999
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-12-29 16:03:12
Reporting Period:: 2016-12-27

Filing Date:: 2016-12-29
Accepted Time:: 2016-12-29 16:03:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1117480	Chimerix Inc	CMRX	Pharmaceutical Preparations (2834)	330903395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1180469	Ernest Mario	C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 100 Durham NC 27713		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-12-27	72,073	$4.68	296,462	No	4	S	Indirect	By The Ernest and Mildred Mario Revocable Trust, Ernest and Mildred Mario, Trustees
Common Stock	Disposition	2016-12-27	3,636	$4.65	292,826	No	4	S	Indirect	By The Ernest and Mildred Mario Revocable Trust, Ernest and Mildred Mario, Trustees
Common Stock	Disposition	2016-12-28	4,000	$4.67	288,826	No	4	S	Indirect	By The Ernest and Mildred Mario Revocable Trust, Ernest and Mildred Mario, Trustees
Common Stock	Disposition	2016-12-28	20,291	$4.52	268,535	No	4	S	Indirect	By The Ernest and Mildred Mario Revocable Trust, Ernest and Mildred Mario, Trustees

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By The Ernest and Mildred Mario Revocable Trust, Ernest and Mildred Mario, Trustees
No	4	S	Indirect	By The Ernest and Mildred Mario Revocable Trust, Ernest and Mildred Mario, Trustees
No	4	S	Indirect	By The Ernest and Mildred Mario Revocable Trust, Ernest and Mildred Mario, Trustees
No	4	S	Indirect	By The Ernest and Mildred Mario Revocable Trust, Ernest and Mildred Mario, Trustees

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,905	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on September 15, 2014.
The range of sale prices received is $4.65 to $4.75. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
72,073 shares held by Reporting Person were inadvertently reported on the prior Form 4 as held directly. Instead an aggregate of 72,073 shares previously reported on Form 4 were held by the Reporting Person indirectly in the name of his trust.
3,636 shares held by Reporting Person were inadvertently reported on the prior Form 4 as held directly. Instead an aggregate of 3,636 shares previously reported on Form 4 were held by the Reporting Person indirectly in the name of his trust.
The range of sale prices received is $4.67 to $4.675. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
4,000 shares held by Reporting Person were inadvertently reported on the prior Form 4 as held directly. Instead an aggregate of 4,000 shares previously reported on Form 4 were held by the Reporting Person indirectly in the name of his trust.
The range of sale prices received is $4.51 to $4.5201. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
20,291 shares held by Reporting Person were inadvertently reported on the prior Form 4 as held directly. Instead an aggregate of 20,291 shares previously reported on Form 4 were held by the Reporting Person indirectly in the name of his trust.